MedTrace Logo

A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic Stroke

NCT06525792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2024-07-29

No results posted yet for this study

Summary

Clinical studies applying ozonated autohemotherapy to treat acute cerebrovascular diseases have validated the safety and efficacy of this treatment, as well as explored its mechanism of action.

Conditions

  • Acute Ischemic Cerebrovascular Disease

Interventions

PROCEDURE

Oxygen

Oxygen and standard therapy were given

PROCEDURE

Ozone

Ozone and standard therapy were given

PROCEDURE

Standard therapy

Best standard of care

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06525792 on ClinicalTrials.gov